Synthetic Biology

Papers
(The TQCC of Synthetic Biology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Construction of a syntrophic Pseudomonas putida consortium with reciprocal substrate processing26
Synthetic biology regulation in Europe: containment, release and beyond24
Development of synthetic biotics as treatment for human diseases19
In vitro transcription-based biosensing of glycolate for prototyping of a complex enzyme cascade18
basicsynbio and the BASIC SEVA collection: software and vectors for an established DNA assembly method16
Utilizing a cell-free protein synthesis platform for the biosynthesis of a natural product, caffeine15
An artificial protein translation language makes bacteria resistant to viruses10
Traditional protocols and optimization methods lead to absent expression in a mycoplasma cell-free gene expression platform10
An injectable CRISPR therapy instructs B cells to produce anti-HIV antibodies9
A new Editor-in-chief for Synthetic Biology9
Development of an expression-tunable multiple protein synthesis system in cell-free reactions using T7-promoter-variant series8
A toolkit for enhanced reproducibility of RNASeq analysis for synthetic biologists8
In- & Out-Cloning: plasmid toolboxes for scarless transcription unit and modular Golden Gate acceptor plasmid assembly8
A mathematical model of cell-free transcription-translation with plasmid crosstalk8
Construction of a mini-RNA replicon inEscherichia coli8
GoldenBraid2.0 E. coli: a comprehensive and characterized toolkit for enterics7
Minimal shuttle vectors for Saccharomyces cerevisiae7
Automated cell segmentation for reproducibility in bioimage analysis7
Variability in cell-free expression reactions can impact qualitative genetic circuit characterization7
Functional Synthetic Biology6
Fighting fire with fire: engineering a microbe into a therapeutic defense against drug-resistant biofilms6
Could a simple model of COVID-19 infections be the key to designing better virus-based therapies?6
Writing the dark matter of the human genome into mice to better replicate human disease6
Rewiring cell-free metabolic flux inE. colilysates using a block—push—pull approach6
0.20991992950439